These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
193 related items for PubMed ID: 10357417
1. Is nuclear expression of Y box-binding protein-1 a new prognostic factor in ovarian serous adenocarcinoma? Kamura T, Yahata H, Amada S, Ogawa S, Sonoda T, Kobayashi H, Mitsumoto M, Kohno K, Kuwano M, Nakano H. Cancer; 1999 Jun 01; 85(11):2450-4. PubMed ID: 10357417 [Abstract] [Full Text] [Related]
2. Increased nuclear localization of transcription factor YB-1 in acquired cisplatin-resistant ovarian cancer. Yahata H, Kobayashi H, Kamura T, Amada S, Hirakawa T, Kohno K, Kuwano M, Nakano H. J Cancer Res Clin Oncol; 2002 Nov 01; 128(11):621-6. PubMed ID: 12458343 [Abstract] [Full Text] [Related]
5. Co-expression of Y box-binding protein-1 and P-glycoprotein as a prognostic marker for survival in epithelial ovarian cancer. Huang X, Ushijima K, Komai K, Takemoto Y, Motoshima S, Kamura T, Kohno K. Gynecol Oncol; 2004 May 01; 93(2):287-91. PubMed ID: 15099935 [Abstract] [Full Text] [Related]
6. Direct involvement of the Y-box binding protein YB-1 in genotoxic stress-induced activation of the human multidrug resistance 1 gene. Ohga T, Uchiumi T, Makino Y, Koike K, Wada M, Kuwano M, Kohno K. J Biol Chem; 1998 Mar 13; 273(11):5997-6000. PubMed ID: 9497311 [Abstract] [Full Text] [Related]
7. Nuclear expression of YB-1 protein correlates with P-glycoprotein expression in human breast carcinoma. Saji H, Toi M, Saji S, Koike M, Kohno K, Kuwano M. Cancer Lett; 2003 Feb 20; 190(2):191-7. PubMed ID: 12565174 [Abstract] [Full Text] [Related]
8. Expression of Y box-binding protein-1 correlates with DNA topoisomerase IIalpha and proliferating cell nuclear antigen expression in lung cancer. Gu C, Oyama T, Osaki T, Kohno K, Yasumoto K. Anticancer Res; 2001 Feb 20; 21(4A):2357-62. PubMed ID: 11724293 [Abstract] [Full Text] [Related]
10. Nuclear localization and increased levels of transcription factor YB-1 in primary human breast cancers are associated with intrinsic MDR1 gene expression. Bargou RC, Jürchott K, Wagener C, Bergmann S, Metzner S, Bommert K, Mapara MY, Winzer KJ, Dietel M, Dörken B, Royer HD. Nat Med; 1997 Apr 20; 3(4):447-50. PubMed ID: 9095180 [Abstract] [Full Text] [Related]
11. Nuclear YB-1 expression as a negative prognostic marker in nonsmall cell lung cancer. Gessner C, Woischwill C, Schumacher A, Liebers U, Kuhn H, Stiehl P, Jürchott K, Royer HD, Witt C, Wolff G. Eur Respir J; 2004 Jan 20; 23(1):14-9. PubMed ID: 14738225 [Abstract] [Full Text] [Related]
12. Drug resistance-associated marker Lrp for prediction of response to chemotherapy and prognoses in advanced ovarian carcinoma. Izquierdo MA, van der Zee AG, Vermorken JB, van der Valk P, Beliën JA, Giaccone G, Scheffer GL, Flens MJ, Pinedo HM, Kenemans P. J Natl Cancer Inst; 1995 Aug 16; 87(16):1230-7. PubMed ID: 7563169 [Abstract] [Full Text] [Related]
13. Y-box factor YB-1 predicts drug resistance and patient outcome in breast cancer independent of clinically relevant tumor biologic factors HER2, uPA and PAI-1. Janz M, Harbeck N, Dettmar P, Berger U, Schmidt A, Jürchott K, Schmitt M, Royer HD. Int J Cancer; 2002 Jan 20; 97(3):278-82. PubMed ID: 11774277 [Abstract] [Full Text] [Related]
14. Nuclear expression of YB-1 protein correlates with P-glycoprotein expression in human osteosarcoma. Oda Y, Sakamoto A, Shinohara N, Ohga T, Uchiumi T, Kohno K, Tsuneyoshi M, Kuwano M, Iwamoto Y. Clin Cancer Res; 1998 Sep 20; 4(9):2273-7. PubMed ID: 9748149 [Abstract] [Full Text] [Related]
15. Nuclear Y-box binding protein-1, a predictive marker of prognosis, is correlated with expression of HER2/ErbB2 and HER3/ErbB3 in non-small cell lung cancer. Kashihara M, Azuma K, Kawahara A, Basaki Y, Hattori S, Yanagawa T, Terazaki Y, Takamori S, Shirouzu K, Aizawa H, Nakano K, Kage M, Kuwano M, Ono M. J Thorac Oncol; 2009 Sep 20; 4(9):1066-74. PubMed ID: 19648825 [Abstract] [Full Text] [Related]
16. Transcription factor Y-box binding protein 1 binds preferentially to cisplatin-modified DNA and interacts with proliferating cell nuclear antigen. Ise T, Nagatani G, Imamura T, Kato K, Takano H, Nomoto M, Izumi H, Ohmori H, Okamoto T, Ohga T, Uchiumi T, Kuwano M, Kohno K. Cancer Res; 1999 Jan 15; 59(2):342-6. PubMed ID: 9927044 [Abstract] [Full Text] [Related]
17. Role of the human Y box-binding protein YB-1 in cellular sensitivity to the DNA-damaging agents cisplatin, mitomycin C, and ultraviolet light. Ohga T, Koike K, Ono M, Makino Y, Itagaki Y, Tanimoto M, Kuwano M, Kohno K. Cancer Res; 1996 Sep 15; 56(18):4224-8. PubMed ID: 8797596 [Abstract] [Full Text] [Related]
18. Expression of PH Domain Leucine-rich Repeat Protein Phosphatase, Forkhead Homeobox Type O 3a and RAD51, and their Relationships with Clinicopathologic Features and Prognosis in Ovarian Serous Adenocarcinoma. Zhang J, Wang JC, Li YH, Wang RX, Fan XM. Chin Med J (Engl); 2017 Feb 05; 130(3):280-287. PubMed ID: 28139510 [Abstract] [Full Text] [Related]
19. Y-box binding protein expression in thyroid neoplasms: its linkage with anaplastic transformation. Ito Y, Yoshida H, Shibahara K, Uruno T, Nakano K, Takamura Y, Miya A, Kobayashi K, Yokozawa T, Matsuzuka F, Uchimi T, Kuwano M, Miyoshi E, Matsuura N, Kuma K, Miyauchi A. Pathol Int; 2003 Jul 05; 53(7):429-33. PubMed ID: 12828607 [Abstract] [Full Text] [Related]